MaMiDaPP: Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
Sponsor
University of Illinois at Urbana-Champaign (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05400382
Collaborator
University of Pittsburgh Medical Center (Other), Southern Illinois University (Other), Arrowhead Regional Medical Center (Other), Feinberg School of Medicine, Northwestern University (Other)
75
2
33
Study Details
Study Description
Brief Summary
This study will test the effect of a mobile mindfulness-based intervention on reducing post-cesarean delivery pain and preventing postpartum depression.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This clinical trial will test the effect of a mobile mindfulness-based intervention on reducing post-cesarean delivery pain and preventing postpartum depression.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
75 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Optimizing Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
Anticipated Study Start Date
:
Jul 1, 2023
Anticipated Primary Completion Date
:
Mar 31, 2026
Anticipated Study Completion Date
:
Mar 31, 2026
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Mindfulness Receiving mobile, self-guided mindfulness intervention |
Behavioral: Mindfulness
Meditation training to help reduce stress and reactivity to pain and other stressors.
Other Names:
|
No Intervention: Treatment as usual with monitoring Receiving treatment as usual with monitoring by study PI and investigators. |
Outcome Measures
Primary Outcome Measures
- Postpartum depression [4 weeks - 6 months]
depressive symptoms EPDS 13 or higher
Secondary Outcome Measures
- Post-operative pain [4 weeks - 6 months]
Post-cesarean delivery pain
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- 18-45 years of age, have a singleton pregnancy, score less than 10 on the Edinburgh Postnatal Depression Scale (EPDS; (Cox et al., 1987b), willing to participate in the eight-week intervention or be randomized to the TAUM condition, have no significant psychiatric disorders other than depression or anxiety (e.g., bipolar disorder, substance use disorder, etc.), have no chronic pain condition (e.g., fibromyalgia), and proficient in English or Spanish
Exclusion Criteria:
- Women who screen 10 or higher on the EPDS
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Illinois at Urbana-Champaign
- University of Pittsburgh Medical Center
- Southern Illinois University
- Arrowhead Regional Medical Center
- Feinberg School of Medicine, Northwestern University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Sandraluz Lara-Cinisomo,
Associate Professor,
University of Illinois at Urbana-Champaign
ClinicalTrials.gov Identifier:
NCT05400382
Other Study ID Numbers:
- MaMiDaPP
First Posted:
Jun 1, 2022
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sandraluz Lara-Cinisomo,
Associate Professor,
University of Illinois at Urbana-Champaign
Additional relevant MeSH terms: